FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966939472> ?p ?o ?g. }

• W1966939472 endingPage "13" @default.
• W1966939472 startingPage "6" @default.
• W1966939472 abstract "Recent studies have demonstrated the evidence of the crucial role of transforming growth factor-β (TGF-β) in the pathogenesis of tissue fibrosis; however, its precise role has not been fully elucidated. Administration of anti-TGF-β antibody is shown to be effective for inhibiting lung fibrosis induced by bleomycin in an experimental animal model. We have recently established a mouse model for scleroderma by repeated injections of bleomycin. In this study, we examined whether the suppression of TGF-β leads to the improvement of dermal sclerotic lesion by using this model. We induced dermal sclerosis in C3H mice by subcutaneous injections of bleomycin (100 μg/ml) for 3 weeks, and separate groups of mice were also injected with bleomycin with either anti-TGF-β antibody (10 μg/ml) or control normal rabbit serum for 3 weeks. Thus treated skins were harvested and analyzed for histological sclerosis, serum cytokine, and influx of mast cells and eosinophils, both of which are known to release fibrogenic cytokines or several mediators responsible for tissue fibrosis. The result showed that anti-TGF-β antibody caused a significant reduction in cutaneous sclerosis characterized by histological features and hydroxyproline contents. Examination of tissue sections also revealed a significant suppression of influx of mast cells and eosinophils. Serum interleukin-4 (IL-4) and IL-6 levels determined by enzyme-linked immunosorbent assay exhibited a significant reduction after anti-TGF-β antibody treatment. Our results suggest that administration of an antibody against TGF-β is useful in preventing experimental dermal sclerosis induced by bleomycin and raises a possibility of the therapeutic approach of anti-TGF-β antibody in scleroderma." @default.
• W1966939472 created "2016-06-24" @default.
• W1966939472 creator A5018050076 @default.
• W1966939472 creator A5049548990 @default.
• W1966939472 creator A5071869091 @default.
• W1966939472 creator A5086696398 @default.
• W1966939472 date "1999-07-01" @default.
• W1966939472 modified "2023-10-17" @default.
• W1966939472 title "Anti-sclerotic Effect of Transforming Growth Factor-β Antibody in a Mouse Model of Bleomycin-Induced Scleroderma" @default.
• W1966939472 cites W1505978562 @default.
• W1966939472 cites W1508850474 @default.
• W1966939472 cites W1563566546 @default.
• W1966939472 cites W1976001496 @default.
• W1966939472 cites W1980490787 @default.
• W1966939472 cites W1983767783 @default.
• W1966939472 cites W1992938929 @default.
• W1966939472 cites W1996385150 @default.
• W1966939472 cites W1996563475 @default.
• W1966939472 cites W2000508527 @default.
• W1966939472 cites W2000708019 @default.
• W1966939472 cites W2003580235 @default.
• W1966939472 cites W2018429730 @default.
• W1966939472 cites W2025297720 @default.
• W1966939472 cites W2034462747 @default.
• W1966939472 cites W2037753264 @default.
• W1966939472 cites W2052388070 @default.
• W1966939472 cites W2071948358 @default.
• W1966939472 cites W2099332798 @default.
• W1966939472 cites W2109534516 @default.
• W1966939472 cites W2111803376 @default.
• W1966939472 cites W2116441979 @default.
• W1966939472 cites W2123550509 @default.
• W1966939472 cites W2129965949 @default.
• W1966939472 cites W2150964219 @default.
• W1966939472 cites W2160001887 @default.
• W1966939472 cites W2168476587 @default.
• W1966939472 cites W2339022261 @default.
• W1966939472 cites W2409552990 @default.
• W1966939472 cites W2419357654 @default.
• W1966939472 doi "https://doi.org/10.1006/clim.1999.4720" @default.
• W1966939472 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10413648" @default.
• W1966939472 hasPublicationYear "1999" @default.
• W1966939472 type Work @default.
• W1966939472 sameAs 1966939472 @default.
• W1966939472 citedByCount "118" @default.
• W1966939472 countsByYear W19669394722012 @default.
• W1966939472 countsByYear W19669394722013 @default.
• W1966939472 countsByYear W19669394722014 @default.
• W1966939472 countsByYear W19669394722015 @default.
• W1966939472 countsByYear W19669394722016 @default.
• W1966939472 countsByYear W19669394722017 @default.
• W1966939472 countsByYear W19669394722020 @default.
• W1966939472 crossrefType "journal-article" @default.
• W1966939472 hasAuthorship W1966939472A5018050076 @default.
• W1966939472 hasAuthorship W1966939472A5049548990 @default.
• W1966939472 hasAuthorship W1966939472A5071869091 @default.
• W1966939472 hasAuthorship W1966939472A5086696398 @default.
• W1966939472 hasConcept C118131993 @default.
• W1966939472 hasConcept C126322002 @default.
• W1966939472 hasConcept C134018914 @default.
• W1966939472 hasConcept C142724271 @default.
• W1966939472 hasConcept C159654299 @default.
• W1966939472 hasConcept C180032290 @default.
• W1966939472 hasConcept C203014093 @default.
• W1966939472 hasConcept C2776232574 @default.
• W1966939472 hasConcept C2776694085 @default.
• W1966939472 hasConcept C2778690821 @default.
• W1966939472 hasConcept C2779797417 @default.
• W1966939472 hasConcept C2779967694 @default.
• W1966939472 hasConcept C2780559512 @default.
• W1966939472 hasConcept C2780942790 @default.
• W1966939472 hasConcept C2781244666 @default.
• W1966939472 hasConcept C71924100 @default.
• W1966939472 hasConceptScore W1966939472C118131993 @default.
• W1966939472 hasConceptScore W1966939472C126322002 @default.
• W1966939472 hasConceptScore W1966939472C134018914 @default.
• W1966939472 hasConceptScore W1966939472C142724271 @default.
• W1966939472 hasConceptScore W1966939472C159654299 @default.
• W1966939472 hasConceptScore W1966939472C180032290 @default.
• W1966939472 hasConceptScore W1966939472C203014093 @default.
• W1966939472 hasConceptScore W1966939472C2776232574 @default.
• W1966939472 hasConceptScore W1966939472C2776694085 @default.
• W1966939472 hasConceptScore W1966939472C2778690821 @default.
• W1966939472 hasConceptScore W1966939472C2779797417 @default.
• W1966939472 hasConceptScore W1966939472C2779967694 @default.
• W1966939472 hasConceptScore W1966939472C2780559512 @default.
• W1966939472 hasConceptScore W1966939472C2780942790 @default.
• W1966939472 hasConceptScore W1966939472C2781244666 @default.
• W1966939472 hasConceptScore W1966939472C71924100 @default.
• W1966939472 hasIssue "1" @default.
• W1966939472 hasLocation W19669394721 @default.
• W1966939472 hasLocation W19669394722 @default.
• W1966939472 hasOpenAccess W1966939472 @default.
• W1966939472 hasPrimaryLocation W19669394721 @default.
• W1966939472 hasRelatedWork W1989331083 @default.
• W1966939472 hasRelatedWork W2049039465 @default.
• W1966939472 hasRelatedWork W2077480094 @default.
• W1966939472 hasRelatedWork W2149962814 @default.

• next